Meeting Report

Sequencing Therapies in Indolent Lymphomas

Presented by Philip A. Thompson, MB, BS, and Lisa Nodzon, PhD, ARNP, AOCNP®

The University of Texas MD Anderson Cancer Center, Houston, Texas; and Moffitt Cancer Center, Tampa, Florida

Presenters’ disclosures of conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2019;10(3):280–286 | https://doi.org/10.6004/jadpro.2019.10.3.15 | © 2019 Harborside™


  

ABSTRACT

Several targeted agents have recently emerged for the treatment chronic lymphocytic leukemia and follicular lymphoma, which has made treatment selection more complex. Philip A. Thompson, MB, BS, and Lisa Nodzon, PhD, ARNP, AOCNP®, described the growing therapeutic landscape of these diseases, as well as how to recognize and manage the toxicities commonly seen with targeted agents.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.